Axaron Bioscience AG
🇩🇪Germany
Treatment With AX200 for Acute Ischemic Stroke
Phase 2
Completed
- Conditions
- Cerebral Stroke
- First Posted Date
- 2005-08-22
- Last Posted Date
- 2007-07-25
- Lead Sponsor
- Axaron Bioscience AG
- Target Recruit Count
- 42
- Registration Number
- NCT00132470
- Locations
- 🇩🇪
Neurology University of Muenster, Muenster, Germany
🇩🇪Neurology University of Heidelberg, Heidelberg, Germany
© Copyright 2025. All Rights Reserved by MedPath